Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 17, 2025

Study Completion Date

June 17, 2025

Conditions

Sickle Cell DiseaseVaso-occlusive Crisis

Trial Locations (3)

Penn Medicine University City, Philadelphia

Pennsylvania Hospital, Philadelphia

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER

NCT06345638 - Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter